News Sentiment

JAGSNPHARM sentiment intelligence

Jagsonpal Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 56 Balanced news tone 17 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 232.77 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Capital return

74/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

-1.6% over one week, +10.1% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Capital return 74/100 classification
One-week reaction -1.6% Price digesting
Trend fit Trend active 10.1% over four weeks
Fair value 23.6% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 11
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
scanx.trade 6
simplywall.st 3
Business Standard 2
ad-hoc-news.de 1
CNBC TV18 1
TradingView 1
The Economic Times 1
Value Research 1

Event Lens

What the news is about

Classified themes
Capital return 7
Market update 5
Deals and strategy 4
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17